Financials Vericel Corporation

Equities

VCEL

US92346J1088

Pharmaceuticals

Delayed Nasdaq 01:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
44.91 USD -0.36% Intraday chart for Vericel Corporation -1.86% +26.12%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 777.7 1,403 1,840 1,244 1,699 2,190 - -
Enterprise Value (EV) 1 777.7 1,403 1,840 1,244 1,699 2,190 2,190 2,190
P/E ratio -79.1 x 515 x -246 x -75.3 x -509 x 376 x 91.4 x 47.8 x
Yield - - - - - - - -
Capitalization / Revenue 6.6 x 11.3 x 11.8 x 7.57 x 8.6 x 9.12 x 7.31 x 5.78 x
EV / Revenue 6.6 x 11.3 x 11.8 x 7.57 x 8.6 x 9.12 x 7.31 x 5.78 x
EV / EBITDA -81.8 x 75.5 x 62.4 x 51.4 x 50.2 x 44.2 x 28.8 x 21.1 x
EV / FCF -79,363,660 x 93,860,642 x - 123,263,648 x - - - -
FCF Yield -0% 0% - 0% - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 44,695 45,429 46,815 47,223 47,725 48,602 - -
Reference price 2 17.40 30.88 39.30 26.34 35.61 45.07 45.07 45.07
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 117.8 124.2 156.2 164.4 197.5 240.3 299.6 378.7
EBITDA 1 -9.507 18.58 29.48 24.2 33.88 49.57 76.12 103.8
EBIT 1 -11.25 2.372 -7.854 -17.06 -6.464 3.428 25.68 52.92
Operating Margin -9.55% 1.91% -5.03% -10.38% -3.27% 1.43% 8.57% 13.97%
Earnings before Tax (EBT) 1 -9.665 3.044 -7.582 -15.99 -2.368 7.379 27.81 53.84
Net income 1 -9.665 2.864 -7.471 -16.71 -3.182 5.482 25.61 49.51
Net margin -8.2% 2.31% -4.78% -10.17% -1.61% 2.28% 8.55% 13.07%
EPS 2 -0.2200 0.0600 -0.1600 -0.3500 -0.0700 0.1200 0.4929 0.9420
Free Cash Flow -9.799 14.95 - 10.09 - - - -
FCF margin -8.31% 12.04% - 6.14% - - - -
FCF Conversion (EBITDA) - 80.42% - 41.7% - - - -
FCF Conversion (Net income) - 521.86% - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 47.59 36.07 37.05 38.55 52.69 41.02 45.92 45.58 65 51.28 52.58 56.07 80.35 63.41 66.65
EBITDA 1 12.77 3.243 2.772 3.325 14.86 1.7 4.441 5.444 22.3 7.218 7.076 8.156 27.13 11.69 12.58
EBIT 1 4.141 -7.273 -9.082 -6.788 6.085 -8.177 -5.961 -5.057 12.73 -5.464 -5.108 -2.857 16.87 -0.5318 -0.0095
Operating Margin 8.7% -20.16% -24.52% -17.61% 11.55% -19.94% -12.98% -11.09% 19.59% -10.66% -9.71% -5.1% 21% -0.84% -0.01%
Earnings before Tax (EBT) 1 4.209 -7.091 -8.963 -6.556 6.622 -7.495 -5.02 -3.946 14.09 -3.862 -4.325 -2.074 17.66 0.0532 0.6002
Net income 1 4.535 -7.091 -8.963 -6.577 5.922 -7.495 -5.02 -3.66 12.99 -3.862 -4.271 -1.865 15.5 0.217 1.081
Net margin 9.53% -19.66% -24.19% -17.06% 11.24% -18.27% -10.93% -8.03% 19.99% -7.53% -8.12% -3.33% 19.29% 0.34% 1.62%
EPS 2 0.0900 -0.1500 -0.1900 -0.1400 0.1300 -0.1600 -0.1100 -0.0800 0.2600 -0.0800 -0.0900 -0.0386 0.2943 0.0100 0.0233
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/24/22 5/4/22 8/3/22 11/9/22 2/23/23 5/10/23 8/2/23 11/8/23 2/29/24 5/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -9.8 14.9 - 10.1 - - - -
ROE (net income / shareholders' equity) - 2.33% - - - - - -
ROA (Net income/ Total Assets) - 1.6% - - - - - -
Assets 1 - 179.4 - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - 2.63 - 7.6 20 19.5 11.8 14.9
Capex / Sales - 2.11% - 4.62% 10.13% 8.09% 3.92% 3.93%
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
45.07 USD
Average target price
55.33 USD
Spread / Average Target
+22.77%
Consensus
  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. Financials Vericel Corporation